Alterini R - Search Results

1

Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.

Rigacci L, Nassi L, Puccioni M, Mappa S, Polito E, Dal Pozzo S, Alterini R, Carrai V, Puccini B, Bosi A. Rigacci L, et al. Among authors: alterini r. Ann Hematol. 2007 Aug;86(8):565-8. doi: 10.1007/s00277-007-0301-y. Epub 2007 May 5. Ann Hematol. 2007. PMID: 17483948 Clinical Trial.

2

Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.

Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A. Rigacci L, et al. Among authors: alterini r. Cancer. 2005 Mar 1;103(5):970-7. doi: 10.1002/cncr.20891. Cancer. 2005. PMID: 15666323 Free article.

3

Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.

Rigacci L, Nassi L, Alterini R, Carrai V, Longo G, Bernardi F, Martini V, Bosi A. Rigacci L, et al. Among authors: alterini r. Acta Haematol. 2006;115(1-2):22-7. doi: 10.1159/000089461. Acta Haematol. 2006. PMID: 16424645 Clinical Trial.

4

Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines.

Rigacci L, Mappa S, Nassi L, Alterini R, Carrai V, Bernardi F, Bosi A. Rigacci L, et al. Among authors: alterini r. Hematol Oncol. 2007 Dec;25(4):198-203. doi: 10.1002/hon.827. Hematol Oncol. 2007. PMID: 17654614 Clinical Trial.

5

Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen: long-term follow-up results.

Rigacci L, Carpaneto A, Alterini R, Carrai V, Bernardi F, Bellesi G, Longo G, Bosi A, Rossi Ferrini P. Rigacci L, et al. Among authors: alterini r. Cancer. 2003 Jan 1;97(1):97-104. doi: 10.1002/cncr.11032. Cancer. 2003. PMID: 12491510 Free article. Review.

6

18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.

Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R, Carrai V, Nassi L, Bernardi F, Pieroni C, Bosi A. Rigacci L, et al. Among authors: alterini r. Oncol Rep. 2005 Nov;14(5):1209-14. Oncol Rep. 2005. PMID: 16211287 Clinical Trial.

7

Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients.

Rigacci L, Landi C, Caruso JP, Puccini B, Alterini R, Carrai V, Perrone T, Bosi A. Rigacci L, et al. Among authors: alterini r. Leuk Res. 2012 Feb;36(2):182-5. doi: 10.1016/j.leukres.2011.06.025. Epub 2011 Jul 14. Leuk Res. 2012. PMID: 21752467 Free article.

8

Patients with ≥ 20 × 10(9)/l platelets at baseline may have a prompt response to romiplostim during the early phase of treatment: an italian single-institution experience.

Baldini S, Rigacci L, Carrai V, Alterini R, Fjerza R, Bosi A. Baldini S, et al. Among authors: alterini r. Mediterr J Hematol Infect Dis. 2012;4(1):e2012044. doi: 10.4084/MJHID.2012.044. Epub 2012 Jun 28. Mediterr J Hematol Infect Dis. 2012. PMID: 22811793 Free PMC article.

9

Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.

Fabbri A, Cencini E, Alterini R, Rubegni P, Rigacci L, Delfino C, Puccini B, Fimiani M, Bosi A, Bocchia M, Pimpinelli N; Gruppo Italiano Linfomi Cutanei (GILC). Fabbri A, et al. Among authors: alterini r. Eur J Haematol. 2014 Aug;93(2):129-36. doi: 10.1111/ejh.12315. Epub 2014 Apr 4. Eur J Haematol. 2014. PMID: 24635751

10

Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone): 25-year experience.

Bellesi G, Rigacci L, Longo G, Alterini R, Bernardi F, Messori A, Trippoli S, Vaiani M, Carrai V, Rossi Ferrini P. Bellesi G, et al. Among authors: alterini r. Oncol Rep. 2000 Jul-Aug;7(4):891-6. doi: 10.3892/or.7.4.891. Oncol Rep. 2000. PMID: 10854565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters